# Dr.MaxHealth > Dr.MaxHealth is a Hamburg-based medical AI company developing PULSE, a patient trajectory intelligence platform built first for US risk-bearing primary care, for longitudinal clinical analysis and physician review. ## Product PULSE: - reconstructs the available longitudinal clinical record; - models patient change over time; - forecasts recurring biomarkers with quantified uncertainty; - coordinates specialized medical reasoning; - connects findings to supporting record observations and relevant medical evidence; - prepares structured output for physician review. PULSE is clinical decision support for qualified healthcare professionals. Output requires review by a qualified healthcare professional; PULSE does not diagnose, prescribe, or act on patients. ## Core PULSE layers - PULSE Timeline - PULSE Trajectory - PULSE Orchestrator - PULSE Evidence Graph - PULSE Review Loop ## Company - Trading name: Dr.MaxHealth - Legal entity: DMH Software UG (haftungsbeschränkt) - Registered: Amtsgericht Hamburg, HRB 196754 - Address: Klaus-Groth-Strasse 77, 20535 Hamburg, Germany - Canonical domain: https://drmaxhealth.de/ (drmaxhealth.org redirects here) ## Primary market Built first for US risk-bearing primary care; relevant to other US healthcare organizations working with longitudinal clinical data. - ACOs, MSOs, and Medicare Advantage-oriented provider groups - Multisite US primary-care and longitudinal-care networks - Clinical and academic research partners ## Status - Retrospective evaluation is in progress; no performance results are published. - Dr.MaxHealth does not claim medical-device certification for PULSE. - Privacy, security, contractual, and deployment requirements for US engagements are assessed during procurement before any patient data is processed. - Institutional programs indicate program participation and support, never clinical endorsement. - Marketing domain: drmaxhealth.de. The separately hosted clinician platform at drmaxhealthplatform.de is limited to authorized evaluation and pilot users. ## Research - Longitudinal patient modeling - Biomarker forecasting - Medical orchestration - Evidence-grounded reasoning - Medical-AI evaluation - Physician–AI collaboration ## Founders - Dr. Maksym Kitsera — Chief Executive Officer. PhD in Microbiology and Virology; former postdoctoral researcher at Bernhard Nocht Institute for Tropical Medicine. ORCID 0000-0003-1214-1313. https://www.linkedin.com/in/maksym-kitsera - Kateryna Velychko — Chief Operating Officer. Operations, program management and clinical partner coordination. https://www.linkedin.com/in/kateryna-velychko ## Institutional support - IFB Hamburg InnoFounder program (via InnovationsStarter) - NVIDIA Inception - Microsoft for Startups - Körber Start-Hub, Hamburg ## Canonical pages - https://drmaxhealth.de/ — positioning and overview - https://drmaxhealth.de/platform — PULSE architecture and product interface - https://drmaxhealth.de/solutions — organizational use cases - https://drmaxhealth.de/science — research program and evaluation methodology - https://drmaxhealth.de/company — founding thesis and founders - https://drmaxhealth.de/updates — dated company developments - https://drmaxhealth.de/investors — investor relations - https://drmaxhealth.de/security — data protection and security posture - https://drmaxhealth.de/book-demo — book a 30-minute PULSE demonstration via Calendly - https://drmaxhealth.de/faq — questions and answers - https://drmaxhealth.de/glossary — definitions of key terms - https://drmaxhealth.de/medical-disclaimer — intended use and clinical limitations - https://drmaxhealth.de/research/ — founder research summary and selected publications - https://drmaxhealth.de/pulse-evaluation-brief.pdf — PULSE Evaluation brief (PDF): scope, stages, and decision gate - https://drmaxhealth.de/impressum — German legal notice - https://drmaxhealth.de/privacy — privacy policy - https://drmaxhealth.de/cookies — cookie policy - https://drmaxhealth.de/sitemap.xml - https://drmaxhealth.de/feed.xml ## Contact - General: office@drmaxhealth.de - Research: maksym.kitsera@drmaxhealth.de - Investor relations: maksym.kitsera@drmaxhealth.de